Baillie Gifford & Co’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $17.8M | Sell |
|
|||||
|
2023
Q1 | $11.3M | Sell |
|
|||||
|
2022
Q4 | $12.8M | Buy |
|
|||||
|
2022
Q3 | $9.13M | Sell |
|
|||||
|
2022
Q2 | $8.83M | Sell |
|
|||||
|
2022
Q1 | $13.3M | Sell |
|
|||||
|
2021
Q4 | $13.8M | Buy |
|
|||||
|
2021
Q3 | $10.7M | Sell |
|
|||||
|
2021
Q2 | $11.9M | Sell |
|
|||||
|
2021
Q1 | $13.1M | Buy |
|
|||||
|
2020
Q4 | $13.4M | Sell |
|
|||||
|
2020
Q3 | $10.4M | Sell |
|
|||||
|
2020
Q2 | $9.89M | Buy |
|
|||||
|
2020
Q1 | $11.7M | Buy |
|
|||||
|
2019
Q4 | $5M | Buy |
|
|||||
|
2019
Q3 | $4.37M | Buy |
|
|||||
|
2019
Q2 | $6.27M | Buy |
|
|||||
|
2019
Q1 | $15.2M | Buy |
|
|||||
|
2018
Q4 | $9.66M | Buy |
|
|||||
|
2018
Q3 | $22.6M | Buy |
|
|||||
|
2018
Q2 | $19.7M | Buy |
|
|||||
|
2018
Q1 | $15.4M | Buy |
|
|||||
|
2017
Q4 | $7.82M | Buy |
|
|||||
|
2017
Q3 | $5.89M | Buy |
|
|||||
|
2017
Q2 | $4.82M | Buy |
|
|||||
|
2017
Q1 | $3.12M | Hold |
|
|||||
|
2016
Q4 | $3.31M | Hold |
|
|||||
|
2016
Q3 | $3.6M | Hold |
|
|||||
|
2016
Q2 | $3.28M | Buy |
|
|||||
|
2016
Q1 | $2.95M | Buy |
|